← Leaderboards
Samuel K S So
Stanford University
$1,779,314
Attributed
$1,891,814
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $629K · FY2007–18$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
CDC$1,558,714 · 2
NIH$333,100 · 1
By mechanism
R18$1,333,714 · 1
R21$333,100 · 1
R43$225,000 · 1
Top collaborators
- Y Andrew Wang1 shared
Most similar at Stanford University
Same institution · by research overlap
- Charles Garrison Fathman$27,441,596
- Katherine W Ferrara$45,937,231
- Mark A Kay$46,920,488
- Harry Bernard Greenberg$91,083,131
- Kim Butts Pauly$23,677,688
Others in their field
Top investigators on “Aftercare”
- Sharon A Nachman · Johns Hopkins University$78,205,219
- Mary M Horowitz · Medical College Of Wisconsin$74,193,785
- Dan H. Barouch · Fred Hutchinson Cancer Center$60,753,467
- Georgia D Tomaras · Fred Hutchinson Cancer Center$58,263,037
- Lawrence Corey · Fred Hutchinson Cancer Center$58,263,037
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,263,037
Research focus
AftercareAntibodiesAssay DevelopmentBaseBenchmarkingBiological MarkersBloodBlood CirculationClinical ResearchDetectionDiagnosisDiagnostic TestsEarly DiagnosisEnzyme-Linked Immunosorbent AssayEvaluationEvaluation/TestingExcisionGenomicsGlypican 3Hepatitis BHepatitis C VirusHybridomasInfectionAblation
Grant awards (6)
Novel Proximity Assay Platform for the Quantitative Detection of Hepatitis B Virus Surface Antigen$225,000
R43 · FY2018 · PS
CD07-005, Translating Research into the Jade Ribbon Campaign$449,210
R18 · FY2009 · PS · contact PI
CD07-005, Translating Research into the Jade Ribbon Campaign$442,252
R18 · FY2008 · PS · contact PI
Development of Glypican-3 as a biomarker for hepatocellular carcinoma$146,400
R21 · FY2008 · CA · contact PI
CD07-005, Translating Research into the Jade Ribbon Campaign$442,252
R18 · FY2007 · PS · contact PI
Development of Glypican-3 as a biomarker for hepatocellular carcinoma$186,700
R21 · FY2007 · CA · contact PI